Yes mate, the potential is truly immense if all goes to plan with registration and bringing the technology to market. One only needs to look back at the success of the last new mode of action to come to market in 2008 - this slide from a previous broker report really puts the opportunity in perspective.
Notice in the slide - Diamides are used in CONJUNCTION with a number of chemicals and insecticides across all 4 of BGT’s targeted verticals. Now think about the most recent announcement regarding synergistic combinations of BGT’s compound, its a significant consideration for the companies who would be looking to strike deals with BGT with respect to their existing manufacturing processes, patents and $$$ etc.
- Forums
- ASX - By Stock
- Ann: Bio-Gene Update Company Presentation
Yes mate, the potential is truly immense if all goes to plan...
Featured News
Add BGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
-0.003(6.00%) |
Mkt cap ! $9.463M |
Open | High | Low | Value | Volume |
5.0¢ | 5.0¢ | 4.7¢ | $997 | 21.19K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10763 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 9000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10763 | 0.046 |
1 | 96000 | 0.044 |
1 | 33333 | 0.043 |
2 | 27375 | 0.040 |
1 | 120050 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 9000 | 1 |
0.050 | 83647 | 2 |
0.052 | 67000 | 1 |
0.061 | 10103 | 1 |
0.063 | 10761 | 1 |
Last trade - 15.58pm 13/11/2024 (20 minute delay) ? |
Featured News
BGT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online